Preprint Review Version 1 This version is not peer-reviewed

Heart in Patients Infected with 2019 Novel Coronavirus (COVID-19)

Version 1 : Received: 18 April 2020 / Approved: 19 April 2020 / Online: 19 April 2020 (13:15:27 CEST)

How to cite: Fayssoil, A.; Davido, B.; Mustafic, H.; Dinh, A.; Mansencal, N. Heart in Patients Infected with 2019 Novel Coronavirus (COVID-19). Preprints 2020, 2020040346 (doi: 10.20944/preprints202004.0346.v1). Fayssoil, A.; Davido, B.; Mustafic, H.; Dinh, A.; Mansencal, N. Heart in Patients Infected with 2019 Novel Coronavirus (COVID-19). Preprints 2020, 2020040346 (doi: 10.20944/preprints202004.0346.v1).

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging infectious disease with currently a pandemic state. Cardiac function can be involved, affecting prognosis, in addition with lung feature severity, particularly in patients with comorbidities. Since the renin angiotensin aldosterone (RAA) system may interact with SARS-Cov-2, researches are still ongoing to assess the prognostic value of RAA blockers in cardiology.

Subject Areas

coronavirus; heart; prognosis; COVID-19; ICU

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.